Malaria Diagnostics Market is estimated to be USD 696.9 million in 2019 and is predicted to reach USD 1,167.3 million by 2030

The Global Malaria Diagnostics Market size is estimated to be USD 696.9 million in 2019 and is predicted to reach USD 1,167.3 million by 2030 with a CAGR of 4.8% from 2020-2030.

Malaria is one of the most common diseases transmitted by female anopheles mosquito and is caused by Plasmodium parasites. A number of different type treatment are available for the treatment of malaria however, continuously increasing number of death due to the disease has acquire the attention for the disease. In 2012, According to the World Health Organization, 203 million cases of malaria were diagnosed, and approximately 0.66 million deaths were occurred across the globe. It is important for accurate and early diagnosis of malaria as the patients recover rapidly if early diagnosed. In sever condition it may causes death.

Access Full Description of this report at:-

https://www.nextmsc.com/report/malaria-diagnostics-market

Top Companies: Access Bio, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott, BioMerieux, Novartis Diagnostics, Lumora, Premier Medical Corporation Ltd., Sysmex Partec GmbH, Siemens Healthineers, Nikon Corporation, Olympus Corporation and others.

Market Dynamics and Trends:

The major driving factors for the global malaria diagnostics market are increasing prevalence of malaria, technological advancements in diagnostic tests and increasing government funding for research & development. QBC technique, serological tests, and peripheral blood smears are some of the most widely used technique for diagnosis of malaria. Additionally, artemether-lumefantrine (Coartem), chloroquine, quinine, clindamycin, atovaquone-proguanil (Malarone), mefloquine (Lariam), and quinidine are some of the majorly used drug for the treatment.

Additionally, rising technological advancement in diagnostic, increasing healthcare spending and rising per capita income have boosted the growth of the market. The advancement in technologies has revolutionized malaria diagnosis and increasing demand for the diagnostic procedures have supported the growth of the market. Rising government funding in healthcare industry, coupled with the increasing investment in R&D is projected affect the growth of the malaria diagnostics market positively. The challenges faced by the global malaria diagnostics market strict regulatory regulations, long approval time, and high cost of research & development. Rapid Diagnostic Tests (RDT’s) is most widely used testing for the diagnosis process. Whereas Molecular diagnostics and detection will be the fastest growing diagnostic test for malaria.

Request sample copy of this report at:-

https://www.nextmsc.com/Malaria-Diagnostics-Market/request-sample

Market Segmentations and Scope of the Study:

The global malaria diagnostics market share is analyzed on the basis of technique and end user. On the basis of technique, the global malaria diagnostics market is segmented into Rapid Diagnostic Tests (RDT), molecular diagnostics, microscopy, and others. On the basis of the end user, the global malaria diagnostics is categorized into hospitals & laboratories, ambulatory centers, and other. The regional analysis of the market comprises of North America, Europe, Asia Pacific, and Rest of the World.

Geographical Analysis:

Asia Pacific and RoW dominate this market, as the prevalence of malaria is high in these regions. Africa has a high prevalence of malaria and majority of deaths are reported in these regions.

North America dominates the global malaria diagnostics market during the forecast period 2019-2030 owing to the presence of well-established diagnostic infrastructure and technological improvements in the field of diagnostics. Asia Pacific malaria diagnostics market is expected to drive significantly during the forecasted period 2020-2030 owing to the presence of huge patient pools and high unmet clinical needs. Europe malaria diagnostics market is driven by rising incidences of lifestyles and infectious diseases.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.